HIV-specific CD8 + T-cell proliferation is prospectively associated with delayed disease progression

Immunology and Cell Biology

Volumn 90, Issue 3, 2012, Pages 346-351

  McKinnon, Lyle R ^a,b   Kaul, Rupert ^a,b,c   Kimani, Joshua ^b,d   Nagelkerke, Nico J ^d,e   Wachihi, Charles ^b   Fowke, Keith R ^b,d   Ball, Terry Blake ^b,d,f   Plummer, Francis A ^b,d,g  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

^e UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^f PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^g PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Africa; CD8 + T cells; female sex workers; HIV AIDS; longitudinal; proliferation

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; GAMMA INTERFERON;

CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CONFERENCE PAPER; CYTOKINE RELEASE; DELAYED DISEASE PROGRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; ENVELOPE GENE; ENZYME LINKED IMMUNOSPOT ASSAY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOREGULATION; INDEPENDENT VARIABLE; INFECTION CONTROL; LONGITUDINAL STUDY; LYMPHOCYTE PROLIFERATION; META ANALYSIS; PROSPECTIVE STUDY; PROSTITUTION; SYSTEMATIC REVIEW; VIRUS IMMUNITY; VIRUS LOAD;

ADULT; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; FOLLOW-UP STUDIES; HIV; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MALE; PROSPECTIVE STUDIES;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84858702556     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2011.44     Document Type: Conference Paper

References (35)

1. Walker BD, Burton DR. Toward an AIDS vaccine. Science 2008; 320: 760-764. (Pubitemid 351929619)
2. Goulder PJ, Watkins DI. Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol 2008; 8: 619-630.
3. Musey L, Hughes J, Schacker T, Shea T, Corey L, McElrath MJ. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl J Med 1997; 337: 1267-1274. (Pubitemid 27461281)
4. Pontesilli O, Klein MR, Kerkhof-Garde SR, Pakker NG, de Wolf F, Schuitemaker H et al. Longitudinal analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte responses: A predominant gag-specific response is associated with nonprogressive infection. J Infect Dis 1998; 178: 1008-1018. (Pubitemid 28452192)
5. Rinaldo C, Huang XL, Fan ZF, Ding M, Beltz L, Logar A et al. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J Virol 1995; 69: 5838-5842.
6. Betts MR, Ambrozak DR, Douek DC, Bonhoeffer S, Brenchley JM, Casazza JP et al. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+)T-cell responses: Relationship to viral load in untreated HIV infection. J Virol 2001; 75: 11983-11991. (Pubitemid 33115870)
7. Draenert R, Verrill CL, Tang Y, Allen TM, Wurcel AG, Boczanowski M et al. Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection. J Virol 2004; 78: 630-641. (Pubitemid 38067584)
8. Addo MM, Yu XG, Rathod A, Cohen D, Eldridge RL, Strick D et al. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol 2003; 77: 2081-2092. (Pubitemid 36110021)
9. Frahm N, Korber BT, Adams CM, Szinger JJ, Draenert R, Addo MM et al. Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J Virol 2004; 78: 2187-2200. (Pubitemid 38228912)
10. 4+ T cells. J Exp Med 2004; 200: 701-712. (Pubitemid 39299457)
11. Horton H, Frank I, Baydo R, Jalbert E, Penn J, Wilson S et al. Preservation of T cell proliferation restricted by protective HLA alleles is critical for immune control of HIV-1 infection. J Immunol 2006; 177: 7406-7415. (Pubitemid 44715111)
12. 8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 2002; 3: 1061-1068. (Pubitemid 35363659)
13. Calarota SA, Foli A, Maserati R, Baldanti F, Paolucci S, Young MA et al. HIV-1-specific T cell precursors with high proliferative capacity correlate with low viremia and high CD4 counts in untreated individuals. J Immunol 2008; 180: 5907-5915.
14. Day CL, Kiepiela P, Leslie AJ, van der Stok M, Nair K, Ismail N et al. Proliferative capacity of epitope-specific CD8 T-cell responses is inversely related to viral load in chronic human immunodeficiency virus type 1 infection. J Virol 2007; 81: 434-438. (Pubitemid 44975185)
15. Miedema F. A brief history of HIV vaccine research: Stepping back to the drawing board? Aids 2008; 22: 1699-1703.
16. Yang OO. Retracing our STEP towards a successful CTL-based HIV-1 vaccine. Vaccine 2008; 26: 3138-3141.
17. Lichterfeld M, Pantaleo G, Altfeld M. Loss of HIV-1-specific T cell proliferation in chronic HIV-1 infection: Cause or consequence of viral replication? Aids 2005; 19: 1225-1227. (Pubitemid 41059265)
18. Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol 2003; 77: 4911-4927. (Pubitemid 36402840)
19. 8+ T cells. PLoS Med 2008; 5: E100.
20. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006; 443: 350-354. (Pubitemid 44435155)
21. 8+ T cells leads to reversible immune dysfunction. Nat Med 2006; 12: 1198-1202. (Pubitemid 44527357)
22. 8+ T cells is critical for superinfection by cytomegalovirus. Science 2010; 328: 102-106.
23. Hansen SG, Vieville C, Whizin N, Coyne-Johnson L, Siess DC, Drummond DD et al. Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat Med 2009; 15: 293-299.
24. Ganesan A, Chattopadhyay PK, Brodie TM, Qin J, Gu W, Mascola JR et al. Immunologic and virologic events in early HIV infection predict subsequent rate of progression. J Infect Dis 2010; 201: 272-284.
25. Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 2003; 4: 1191-1198. (Pubitemid 37540688)
26. Hirbod T, Kaul R, Reichard C, Kimani J, Ngugi E, Bwayo JJ et al. HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers. Aids 2008; 22: 727-735. (Pubitemid 351450641)
27. 8+ T-cell responses prior to HIV acquisition. Aids 2010; 24: 1449-1454.
28. Kaul R, Rutherford J, Rowland-Jones SL, Kimani J, Onyango JI, Fowke K et al. HIV-1 Env-specific cytotoxic T-lymphocyte responses in exposed, uninfected Kenyan sex workers: A prospective analysis. Aids 2004; 18: 2087-2089. (Pubitemid 39463364)
29. 8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 2007; 13: 46-53. (Pubitemid 46067385)
30. Betts MR, Krowka JF, Kepler TB, Davidian M, Christopherson C, Kwok S et al. Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors. AIDS Res Hum Retroviruses 1999; 15: 1219-1228. (Pubitemid 29411807)
31. Chen DY, Balamurugan A, Ng HL, Yang OO. Antiviral activity of HIV-1 gag-specific cytotoxic T lymphocyte targeting is not necessarily intrinsically superior to envelope targeting. J Virol 2011; 85: 2474-2478.
32. 8+ T cells does not predict AIDS-free survival time. PLoS ONE 2008; 3: E2745.
33. Brumme Z, Wang B, Nair K, Brumme C, de Pierres C, Reddy S et al. Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: Results from Sinikithemba Cohort, Durban, South Africa. Clin Infect Dis 2009; 49: 956-964.
34. 8+ T cells in a cohort dominated by clade A1 infection. PLoS One 2009; 4: E6965.
35. 8+ T cells. J Immunol 2007; 178: 3750-3756. (Pubitemid 46417643)